ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
16 juni, 23:31
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
PR Newswire
NEW YORK, June 16, 2025
NEW YORK , June 16, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Sage Therapeutics, Inc. (NASDAQ: SAGE) and its board of directors concerning the proposed acquisition of the company by Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN). Stockholders will receive $8.50 and once contingent value right worth up to $3.50 for each share of Sage Therapeutics, Inc. stock that they hold. The transaction is valued between $561 million and $795 million and is expected to close in the third quarter of 2025.
If you are a stockholder of Sage Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/sage/ . You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com , or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com .
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
Ämnen i artikeln
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
16 juni, 23:31
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
PR Newswire
NEW YORK, June 16, 2025
NEW YORK , June 16, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Sage Therapeutics, Inc. (NASDAQ: SAGE) and its board of directors concerning the proposed acquisition of the company by Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN). Stockholders will receive $8.50 and once contingent value right worth up to $3.50 for each share of Sage Therapeutics, Inc. stock that they hold. The transaction is valued between $561 million and $795 million and is expected to close in the third quarter of 2025.
If you are a stockholder of Sage Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/sage/ . You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com , or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com .
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
Ämnen i artikeln
-160x160.jpg&w=3840&q=75)
Styrräntan
.jpg&w=3840&q=75)
Aktier
.jpg&w=3840&q=75)
Bostadsmarknaden
Mest läst
Styrräntan
Aktier
Bostadsmarknaden
Senaste nytt
Idag, 08:20
Powell: "Någon måste betala för tullarna”
Saab
Igår, 18:57
Frankrike avser köpa Globaleye
Kambi Group
Igår, 18:49
Kambi beslutar om aktieåterköp
Marknadsöversikt
OMX Stockholm 30
1 DAG %
0,00%
Senast
2 458,59
1 mån
Loading market data...
Privatekonomi med Placeras expert
Affärsvärlden
.jpg&w=3840&q=75)